Skip to main content
Skip to footer
Home
About Us
Our Mission & History
Leadership Team
Pipeline
Products
Business Development
News
Careers
Contact
Category:
News & Media
Solaris Pharma Receives FDA Approval for First Generic Clindamycin Phosphate Topical Gel, 1%
August 23, 2021
BRIDGEWATER, N.J., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Solaris Pharma Corporation (“Solaris” or the “Company”) announced today that the Company…
August 23, 2021BRIDGEWATER, N.J., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Solaris Pharma Corporation (“Solaris” or the “Company”) announced today that the Company…
